首页> 外国专利> Controlled release gelatin capsules - in which the gelatin shell is insolubilized with a crosslinking agent

Controlled release gelatin capsules - in which the gelatin shell is insolubilized with a crosslinking agent

机译:控释明胶胶囊-其中明胶壳不溶于交联剂

摘要

New capsules provide for the controlled release through the capsule walls of therapeutic agents they contain. The capsule walls contain crosslinked gelatin which is insoluble in basic and acidic body fluids. The gelatin may be hard or soft the gelatin. The new capsules can be produced by existing encapsulation technology with very little modification. The sustained release characteristics of the capsules are independent of the pH of the surrounding body-fluid, so that therapeutic agent continues to be released in a controlled manner throughout the passage of the capsule through the gastro-intestinal tract. In an example, commercial hard-shell gelatin capsules are insolubilised by treating with a 1% solution of glutaraldehyde in 0.05-M phosphate buffer pH 7. After washing and drying, the capsules are filled with 37 mg amitriptyline hydrochloride, then the two capsule halves are sealed together with an epoxy resin. The rate of release of active substance from the capsule in water is 3.5 mg/hr. on average.
机译:新的胶囊提供了它们所包含的治疗剂通过胶囊壁的受控释放。胶囊壁含有不溶于碱性和酸性体液的交联明胶。明胶可以是硬的或软的。新的胶囊可以通过现有的封装技术进行生产,而无需进行任何改动。胶囊的持续释放特性与周围体液的pH值无关,因此治疗剂在胶囊通过胃肠道的整个过程中继续以受控方式释放。在一个实例中,通过用1%戊二醛在0.05M磷酸盐缓冲液pH 7中的溶液处理来使商业硬壳明胶胶囊不溶。洗涤并干燥后,将所述胶囊填充37mg阿米替林盐酸盐,然后将两半胶囊填充用环氧树脂密封在一起。活性物质从胶囊在水中的释放速率为3.5 mg / hr。一般。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号